Hillrom and Welch Allyn are a part of Baxter.
23px-Flag_baxterUS.svg.png  United States
text.skipToContent text.skipToNavigation
  1. Baxter Catalog
  2. Pharmaceuticals
  3. Vials & Other Injectables
  4. Gentamicin Sulfate in 0.9% Sodium Chloride Injection, 80 mg/50 mL in VIAFLEX Plastic Container. Liquid Premix.
Due to missing information on your Hillrom Direct account, you are not able to add items to the cart or continue with the checkout process. Please contact our customer support team for further assistance by clicking on "contact us".
MP_logo
Gentamicin Sulfate in 0.9% Sodium Chloride Injection, 80 mg/50 mL in VIAFLEX Plastic Container. Liquid Premix.
Item Number: 2B0852
GTIN:  0303380509416
GTIN-CS:  50303380509411
Gentamicin Sulfate in 0.9% Sodium Chloride Injection, 80 mg/50 mL in VIAFLEX Plastic Container. Liquid Premix. Please refer to full Prescribing Information, including Boxed Warning. NDC 0338-0509-41
print-icon Print email-icon Email
Email PDF ✕
Specifications

Product Characteristics

Minimum Storage Temperature 0.0 °C
Maximum Storage Temperature 0.0 °C
Volume 50.0 ml
Shelf Life from Manufacture 18 months
Concentration 1.6 mg/mL
Container Type VIAFLEX
Containes Preservative No
Diluent Sodium Chloride
Dosage Form Liquid
Drug Class Anti-Infective
Rx Only Yes
Storage Recommendations Store at room temperature 25°C (77°F), brief exposure up to 40° C (104° F) does not adversely affect the product.
Strength 80 mg/50 mL

Carton

Units per Case 24.0
Carton Weight 4.85 lb.
Carton Length 12.2 in.
Carton Width 9.84 in.
Carton Height 4.5 in.
Carton Volume 0.31 fc

Reimbursement Information

HCPCS Code HCPCS Description
J1580 INJECTION, GARAMYCIN, GENTAMICIN, UP TO 80 MG
A4216 STERILE WATER, SALINE AND/OR DEXTROSE, DILUENT/FLUSH, 10 ML
Medication Delivery Reimbursement Hotline 888-338-0001

Information Source : CMS

Disclaimer:The coverage, coding, and payment information included in this guide has been compiled from various resources for informational use as a tool to assist providers with reimbursement issues. This information is current as of 3/31/2008; however this information is subject to change and should not be construed as legal advice. Providers should exercise independent clinical judgment when selecting codes and submitting claims to accurately reflect services rendered to individual patients. Baxter Healthcare Corporation does not guarantee success in obtaining insurance payments. Providers are encouraged to contact third-party payors for specific information on their coverage, coding, and payment policies.
Ordering Information
Item Number 2B0852
Sales Unit case
GTIN 0303380509416
GTIN-CS 50303380509411
National Drug Code 00338050941

     203052r1